Humane Genomics
YC S21New York City, US · Founded 2019 · 5 employees · 7 known investors
Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.
BiotechDeep TechHealthtechMedical DevicesHard TechSynthetic BiologyUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S21)
Humane Genomics was founded in 2019 by Peter Weijmarshausen and Chad Moles.
PW
Peter Weijmarshausenin𝕏CEO / Co-founderPeter Weijmarshausen is a founder and former CEO of Shapeways who has built software and product teams across multiple companies. He holds a BSc in Applied Physics and is now developing a platform for artificial virus-based cancer therapeutics.
CM
Chad Molesin𝕏Co-founder and Chief Science OfficerChad Moles has worked in biotech and public health, with education from Columbia and Tulane. He is building a platform to engineer viruses for cancer therapy applications.
Investors · 7
.jpeg){kind=logo}
Funding
SEC filings, press & company announcements- Undisclosed amountSeedFeb 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapRead on Scientific American12 shared keywordsScientific American is a science and technology news publication covering research, discoveries, and developments across fields such as astronomy, biology, physics, health, and climate. It publishes articles, magazine issues, discussions, and organizes reader travel experiences and editorial features.
Pano AI11 shared keywordsPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.
Companies competing with Humane Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Humane Genomics do?
- Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.
- Who founded Humane Genomics?
- Humane Genomics was founded by Peter Weijmarshausen, Chad Moles in 2019.
- Who are Humane Genomics's investors?
- Humane Genomics's investors include 2048 Ventures, Humba Ventures, Leo Capital Ventures, LifeX Ventures, Red Beard Ventures, Union Square Ventures (USV), Y Combinator.
- Where is Humane Genomics headquartered?
- Humane Genomics is headquartered in New York City, US.